Please read our acceptance criteria, the required sample types and guidance on transport and delivery before submitting samples for testing. For cancer referrals please refer to the cancer referral guidelines.
Patient referral forms
- Referral to Urgency Genetics Clinic
- Neonatal Urgent Genetics Referral Form
- Consent Form for Assessment by a Clinical Geneticist (patient deceased)
- For cytogenetic (chromosomal) and molecular (DNA) testing use our joint referral form.
- Samples to be exported to other laboratories must be accompanied by either our molecular testing referrals requiring export form, or our biochemical export form
- For biochemical genetics testing use the Willink referral form.
- For cystic fibrosis carrier testing direct to general practitioners use the CF carrier request form.
Specialist Sample referrals
- For specialist cell culture service samples use the specialist cell culture service referral form.
- For KRAS and BRAF testing in non-melanoma samples, use either the KRAS & BRAF request form (if sending to MCGM) or the KRAS & BRAF Pathology form (if sending to the pathology lab that holds the sample).
- For BRAF testing in melanoma samples, use the BRAF Melanoma request form.
- For EGFR mutation testing, use:
- The EGFR request form where a pathology sample is available;
- The cfDNA EGFR request form to test using plasma when biopsy testing is not possible, has failed or is inconclusive
- For cfDNA EGFR service evaluation information and request form to accompany samples.
- For PIK3CA mutation testing (clinical trials/research), use the PIK3CA request form.
- For ALK testing in NSCLC, use the ALK request form.
- For Somatic Cancer panel (NGS) testing (formerly Oncocarta & Lungcarta) use either the Somatic Cancer panel (NGS) Genetics form (if you require MCGM to obtain the sample) or Somatic Cancer panel (NGS) Pathology form (if sending direct to the Pathology lab holding the sample).
- For diagnostic mismatch repair IHC testing in colorectal cancer cases, please see our Histopathology Laboratory Service.
- For tumour BRCA1/2 mutation testing in platinum sensitive relapsed ovarian cancer patients, use the Tumour BRCA1/2 testing - treatment focussed request form.
- For BRCA1/2 mutation testing in pathology material from deceased relatives, use the Familial BRCA1/2 testing in pathology material request form.
- High risk samples must be clearly labelled as such with the specific risk identified where appropriate.
- Samples to be tested for a diagnosis of Huntington Disease must be accompanied by a consent form. Presymptomatic tests should be referred through a Genetics Centre.
- Samples for rare disease testing must be accompanied by a rare disease form.
- Samples referred externally for mutation screening of the NF1 gene must be accompanied by the mandatory NF1 pro-forma.
- Samples to be tested for mutation screening of the NF2 gene must be accompanied by a clinical questionnaire.